How we view and approach transfusion-associated circulatory overload: Pathogenesis, diagnosis, management, mitigation, and prevention

Transfusion

Volumn 53, Issue 12, 2013, Pages 3037-3047

  Andrzejewski, Chester ^a   Casey, Mark A ^b,c   Popovsky, Mark A ^d,e  

^a BAYSTATE HEALTH   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c Cooley Dickinson Hospital ^*  (United States)

^d HAEMONETICS CORPORATION   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; FUROSEMIDE; HYPERTENSIVE FACTOR; INFUSION FLUID; OXYGEN;

ARTICLE; BLOOD BANK; BLOOD COMPONENT THERAPY; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CENTRAL VENOUS PRESSURE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DISEASE EXACERBATION; DIURETIC THERAPY; DYSPNEA; EPIDEMIOLOGY; ERYTHROCYTE TRANSFUSION; FATALITY; FEVER; FLUID BALANCE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEART LEFT VENTRICLE FAILURE; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; HYDROSTATIC PRESSURE; HYPERTENSION; HYPERVOLEMIA; ICD-9-CM; INFLAMMATION; INTENSIVE CARE UNIT; LUNG BLOOD VESSEL; LUNG CONGESTION; LUNG EDEMA; MULTICENTER STUDY (TOPIC); OXYGEN THERAPY; PATHOGENESIS; PATIENT CARE; PULSE PRESSURE; RESPIRATORY DISTRESS; RISK FACTOR; TACHYCARDIA; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT RESPONSE; VEIN DILATATION; WEIGHT CHANGE;

EID: 84890442372     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12454     Document Type: Article

References (41)

1. Bernheim BM,. Blood transfusion hemorrhage and the anemias. Philadelphia (PA): Lippincott; 1917. pp. 53-60, 104-5.
2. Plummer NS,. Blood transfusion, a report of six facilities. Br Med J 1936; 2: 1186-1189.
3. Drummond R,. Transfusion reactions and fatalities consequent on circulatory overloading. Br Med J 1943; 2: 319-322.
4. Scott RB,. Complications of blood transfusion (section III). In:, Keyes G, Brewer HF, editors. Blood transfusion. Baltimore (MD): Williams and Wilkins; 1949. pp. 134-135, 182-6.
5. Popovsky MA, Audet AM, Andrzejewski C Jr,. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996; 12: 87-89.
6. Serious Hazards of Transfusion (SHOT). Definitions of current SHOT categories and what to report. Revised November 2012. [cited 2013 Mar 20]. Available from: http://www.shotuk.org/wp-content/uploads/2010/03/SHOT- definitions-Nov012-final.pdf
7. Ellsworth B, Ellsworth P, Stevens WT,. Adverse reaction case definition criteria from Appendix A of the Biovigilance Component of the National Healthcare Safety Network (NHSN) manual. 2013. [cited 2013 Oct 15]. Available from: http://www.cdc.gov/nhsn/bio.html
8. Pomper GJ,. Febrile, allergic and nonimmune transfusion reactions. In:, Simon TL, Snyder EL, Solheim BG, et al., editors. Rossi's principles of transfusion medicine. 4th ed. Bethesda (MD): American Association of Blood Banks Press; 2009. pp. 826-846.
9. Popovsky MA,. Transfusion-associated circulatory overload. In:, Popovsky MA, editor. Transfusion reactions. 4th ed. Bethesda (MD): American Association of Blood Banks Press; 2012. pp. 327-337.
10. Giblett ER,. Blood groups and blood transfusion. In:, Thorn GW, Adams RD, Braunwald E, et al., editors. Harrison's principles of internal medicine. 8th ed. New York: McGraw-Hill, Inc; 1977. p. 1705.
11. Cohen H,. Transfusion-associated circulatory overload (TACO). In: Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report. 2012. pp. 114-118 [cited 2013 Mar 19]. Available from: http://www.shotuk.org/wp- content/uploads/2012/07/SHOT-ANNUAL-REPORT-FinalWebVersionBookmarked-2012-06-22. pdf
12. Zhou I, Giacherio D, Cooling L, et al. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005; 45: 1056-1063.
13. Tobian AA, Sokoll LJ, Tisch DJ, et al. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008; 48: 1143-1150.
14. Andrzejewski C Jr, Popovsky MA,. Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 2005; 45: 1048-1050.
15. Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009; 29: 13-20.
16. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2010. Rockville, MD: CBER Office of Communication, Outreach, and Development. 2011 [cited 2012 Feb 28]. Available from: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm302847.htm
17. David B,. Haemovigilance: a comparison of three national systems. 27th Congress of the International Society of the Blood Transfusion, 24-28 August 2002. Vancouver.
18. Robillard P, Itaj NK, Chapdelaine A,. Increasing incidence of transfusion-associated circulatory overload reported to the Quebec Hemovigilance System, 2000-2006. Transfusion 2008; 48 (Suppl): 204A.
19. Narick C, Triulzi DJ, Yazer MH,. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012; 52: 160-165.
20. Murphy EL, Kwaan N, Looney M, et al. Risk factors and outcomes in transfusion associated circulatory overload (TACO). Am J Med 2013; 126: 357.e29-35738.
21. Bierbaum B, Callaghan J, Galante J, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
22. Robillard P, Nawej K, Chapdelaine A,. Transfusion-associated circulatory overload (TACO): current leading cause of transfusion associated fatalities reported to the Québec Hemovigilance System. Transfus Med 2009; 19: 280-281.
23. Popovsky MA, Taswell HF,. Circulatory overload: an underdiagnosed consequence of transfusion. Transfusion 1985; 25: 469.
24. Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51: 338-343.
25. Bux J, Sachs UJH,. Pulmonary transfusion reactions. Transfus Med Hemother 2008; 35: 337-345.
26. Andrzejewski C Jr, Popovsky MA, Stec TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion associated circulatory overload have proinflammatory aspects? Transfusion 2012; 52: 2310-2320.
27. Andrzejewski C Jr, McGirr J,. Nursing hemotherapy bedside biovigilance in the recognition and management of suspected transfusion reactions. In:, Popovsky MA, editor. Transfusion reactions. 4th ed. Bethesda (MD): American Association of Blood Banks Press; 2012. pp. 551-577.
28. Katz EA,. Blood transfusion, friend or foe. AACN Adv Crit Care 2009; 20: 155-163.
29. Robillard P, Itaj K, Chapdelaine A,. Transfusion-Associated Circulatory Overload (TACO): The new leading cause of transfusion-associated fatalities reported to the Québec Hemovigilance System. [cited 2013 Mar 20]. Available from: http://ihn.withtoast.co.uk/wpcontent/uploads/2011/02/TACO-data- 2000-2008-Poster-ISBT-2010.pdf
30. Blumberg N, Heal JM, Gettings KF, et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50: 2738-2744.
31. Ewald GA, Garmany RG, Krainik AJ,. Heart failure, cardiomyopathy, and valvular heart disease. In:, Cooper DH, Krainik AJ, Lubner SJ, et al., editors. The Washington manual of medical therapeutics. 32nd ed. Philadelphia (PA): Wolters Kluwer, Lippincott Williams & Wilkins; 2007. pp. 170, 173.
32. Finlay HE, Cassorla L, Feiner J, et al. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol 2005; 124: 601-609.
33. Clifford L, Singh A, Wilson GA, et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 2013; 53: 1205-1216.
34. Skeate RC,. Transfusion medicine data as product. Transfusion 2013; 53: 1153-1156.
35. Hill S, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion (Review). The Cochrane Collaboration. John Wiley & Sons, Ltd. 2009 [cited 2013 Apr 2]. Available from: http://www.thecochranelibrary.com/userfiles/ccoch/file/CD002042. pdf
36. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
37. Roberts I, Evans P, Bunn F, et al. Is the normalization of blood pressure in bleeding trauma patients harmful? Lancet 2001; 357: 385-387.
38. Stern SA, Dronen SC, Birrer P, et al. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med 1993; 22: 155-163.
39. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-1789.
40. Shaz BH, Stowell SR, Hillyer CD,. Transfusion-related acute lung injury: from bedside to bench and back. Blood 2011; 117: 1463-1482.
41. Kopko PM, Popovsky MA,. Transfusion-related acute lung injury. In:, Popovsky MA, editor. Transfusion reactions. 4th ed. Bethesda (MD): American Association of Blood Banks Press; 2012. pp. 191-215.